BCRX Charles K. Gayer bought BIOCRYST PHARMACEUTICALS INC shares — SEC Form 4BUYBIOCRYST PHARMACEUTICALS INC

Charles K. Gayer, Chief Commercial Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 30,000 shares at $5.47 ($164K) on 2024-05-13, disclosed to the SEC on 2024-05-15.

SEC EDGAR Filing

0001127602-24-015363

View on SEC EDGAR

Why this matters (generating…)

High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.

Notable60/100

Something here stands out, but not much.

First-Time BuyerLarge Holdings IncreaseOpportunistic BuyDeep Dip Buy

Trade Context

•Increased holdings by 11%
•3 other insiders also purchased in last 30 days
•Stock up +18% in previous month
•Mid-Cap ($2B-$10B market cap)

Filing Info

Filed2024-05-15

Traded2024-05-13

Accession0001127602-24-015363

SourceSEC EDGAR (Historical)

Insider

NameCharles K. Gayer

TitleChief Commercial Officer

PIT GradeInsiderUnrated

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
BCRX	SELL	2022-12-19	$66K	—	Filing →

Get an email when an insider at BCRX files

Free account. Follow BCRX and up to 10 more companies.

Follow BCRX for free

BCRX Charles K. Gayer bought BIOCRYST PHARMACEUTICALS INC shares — SEC Form 4BUYBIOCRYST PHARMACEUTICALS INC

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes